Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Novartis
Pharmaceuticals
Bristol Myers Squibb
AstraZeneca
GSK
Johnson and Johnson
Sanofi
Pfizer
Topics

Advertisement

Advertisement

Novartis

Share

Top Latest Popular

Novartis to cut up to 130 jobs in Basel Swiss Info 6d

Swiss Info 6d

Novartis halts clinical trials following patient deaths Swiss Info 7d

Swiss Info 7d

STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 3d

STAT 3d

Novartis strikes $3.2 billion deal with Alteogen as drug delivery patent licences pile up IAM 4d

IAM 4d

Advertisement

Novartis pauses autoimmune cell therapy studies after deaths Times LIVE 7d

Times LIVE 7d

Novartis sets sights on new oral MS drug after phase 3 wins pharmaphorum 7d

pharmaphorum 7d

Advertisement

Advertisement

Latest

In the last 5 minutes

European shares dip as higher crude revives inflation worries; Novartis drags Business Recorder, Pakistan 08:33

STAT Plus: Neuromuscular drug from Novartis fails in key study, adding to pressure on company STAT 08:32

In the last 4 hours

Novartis enters into exclusive promotion and distribution agreement with Novartis Healthcare The Business Standard 06:12

Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1) Novartis (Press Release) 06:09

Yesterday

Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down Zacks 17:53 Mon, 07 Sep

European shares subdued as surging crude sharpens focus on ECB rate path The Economic Times 17:52 Mon, 07 Sep

Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal Zacks 17:33 Mon, 07 Sep

360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr The Economic Times 16:51 Mon, 07 Sep

Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for ₹1,250 crore The Hindu Business Line 14:46 Mon, 07 Sep

Novartis India buys Minipress brands from Pfizer for ₹1,250 crore The Business Standard 13:10 Mon, 07 Sep

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis